Form 4: ADMA Biologics Director Jerrold B. Grossman Reports Stock and Option Transactions
SEC Form 4 Filing
Director Jerrold B. Grossman reports acquisition of restricted stock units and stock options in ADMA Biologics, along with adjustments to beneficial ownership.
Summary
- Jerrold B. Grossman, a director of ADMA Biologics, filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
- On February 19, 2025, Grossman acquired 10,889 restricted stock units (RSUs) and 16,279 stock options.
- The RSUs vest in two equal installments over a year, while the options vest monthly over a year.
- Grossman's direct holdings include 478,194 shares of common stock, including the newly granted RSUs.
- He also has indirect ownership through Brookwood LLC (22,857 shares), the Jerrold Grossman 2019 Irrevocable Trust (31,381 shares), Genesis Foundation Inc. (38,294 shares), and shares owned by his wife (175 shares).
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating insider transactions, which can be seen as a positive sign of confidence, but doesn't provide enough information to strongly skew positive or negative.
Positives
- The acquisition of RSUs and stock options by a director signals confidence in the company's future performance.
- The vesting schedules of the RSUs and options incentivize continued service and alignment with shareholder interests.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting schedules suggest a commitment to the company's long-term success.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the director's ongoing investment in the company.
Stakeholder Impact
- Shareholders may view the director's stock and option acquisitions as a positive signal.
- The transactions have no immediate impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 02/26/2024 | Grant date of 12,020 restricted stock units that will vest in full on February 26, 2025. |
| 02/19/2025 | Date of transaction: Acquisition of 10,889 RSUs and 16,279 stock options. |
| 02/21/2025 | Date of Form 4 filing. |
| 02/26/2025 | Vesting date of 12,020 restricted stock units granted on February 26, 2024. |
| 02/19/2035 | Expiration date of the stock options. |
Keywords
ADMA Biologics, Form 4, Beneficial Ownership, Jerrold Grossman, Stock Options, Restricted Stock Units, Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.